U.S. Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report By Service (Manufacturing, Drug Delivery Formulations, Finished Dose Formulations, Research), And Segment Forecasts, 2024 - 2030­

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                      1.2. Segment Definitions
                          1.2.1. Service
                          1.2.2. Estimates and forecasts timeline
                      1.3. Research Methodology
                      1.4. Information Procurement
                          1.4.1. Purchased database
                          1.4.2. GVR’s internal database
                          1.4.3. Secondary sources
                          1.4.4. Primary research
                          1.4.5. Details of primary research
                              1.4.5.1. Data for primary interviews in U.S.
                      1.5. Information or Data Analysis
                          1.5.1. Data analysis models
                      1.6. Market Formulation & Validation
                      1.7. Model Details
                          1.7.1. Commodity flow analysis (Model 1)
                          1.7.2. Approach 1: Commodity flow approach
                      1.8. List of Secondary Sources
                      1.9. List of Primary Sources
                      1.10. Objectives
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Service Outlook
                      2.3. Competitive Insights
Chapter 3. U.S. Pharmaceutical Contract Manufacturing and Research Services Market Variables, Trends & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Market Dynamics
                          3.2.1. Market driver analysis
                              3.2.1.1. Drug shortage driving demand for pharmaceutical development
                              3.2.1.2. Commercial success of biologics for clinical use
                              3.2.1.3. Lower manufacturing costs and improving economic condition of BRIC
                          3.2.2. Market restraint analysis
                              3.2.2.1. Limited outsourcing opted by big pharma companies
                              3.2.2.2. Regulatory issues pertaining to the drug approval
                              3.3. U.S. Pharmaceutical Contract Manufacturing and Research Services Market Analysis Tools
                          3.3.1. Industry Analysis - Porter’s Five Forces
                              3.3.1.1. Bargaining power of buyers
                              3.3.1.2. Bargaining power of suppliers
                              3.3.1.3. Competitive rivalry
                              3.3.1.4. Threat of new entrant
                              3.3.1.5. Threat of substitutes
                          3.3.2. PESTEL Analysis
                              3.3.2.1. Political & legal landscape
                              3.3.2.2. Economic landscape
                              3.3.2.3. Technological & social landscape
Chapter 4. U.S. Pharmaceutical Contract Manufacturing and Research Services Market: Service Estimates & Trend Analysis
                     4.1. U.S. Pharmaceutical Contract Manufacturing and Research Services Market: Service Dashboard
                     4.2. U.S. Pharmaceutical Contract Manufacturing and Research Services Market: Service Movement Analysis
                     4.3. U.S. Pharmaceutical Contract Manufacturing and Research Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                     4.4. Manufacturing
                          4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.4.2. API/Bulk Drugs
                              4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.4.3. Advanced Drug Delivery Formulations Packaging
                              4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.4.4. Packaging
                              4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.4.5. Finished Dose Formulations
                              4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.5.2. Solid Formulations
                                  4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.5.3. Liquid Formulations
                                  4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                              4.4.5.4. Semi-solid Formulations
                                  4.4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      4.5. Research
                          4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.5.2. Oncology
                              4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.5.3. Vaccines
                              4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.5.4. Inflammation & Immunology
                              4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.5.5. Cardiology
                              4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.5.6. Neuroscience
                              4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                          4.5.7. Others
                              4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. Competitive Landscape
                      5.1. Recent Developments & Impact Analysis, By Key Market Participants
                      5.2. Company/Competition Categorization
                      5.3. Vendor Landscape
                          5.3.1. List of key distributors and channel partners
                          5.3.2. Key customers
                          5.3.3. Key company market share analysis, 2023
                          5.3.4. Catalent
                              5.3.4.1. Company overview
                              5.3.4.2. Financial performance
                              5.3.4.3. Product benchmarking
                              5.3.4.4. Strategic initiatives
                          5.3.5. Pfizer (CentreOne)
                              5.3.5.1. Company overview
                              5.3.5.2. Financial performance
                              5.3.5.3. Product benchmarking
                              5.3.5.4. Strategic initiatives
                          5.3.6. Charles River Laboratories International, Inc.
                              5.3.6.1. Company overview
                              5.3.6.2. Financial performance
                              5.3.6.3. Product benchmarking
                              5.3.6.4. Strategic initiatives
                          5.3.7. Albany Molecular Research, Inc.
                              5.3.7.1. Company overview
                              5.3.7.2. Financial performance
                              5.3.7.3. Product benchmarking
                              5.3.7.4. Strategic initiatives
                          5.3.8. Laboratory Corporation of America Holdings (LabCorp)
                              5.3.8.1. Company overview
                              5.3.8.2. Financial performance
                              5.3.8.3. Product benchmarking
                              5.3.8.4. Strategic initiatives
                          5.3.9. IQVIA
                              5.3.9.1. Company overview
                              5.3.9.2. Financial performance
                              5.3.9.3. Product benchmarking
                              5.3.9.4. Strategic initiatives
                          5.3.10. Baxter BioPharma Solutions
                              5.3.10.1. Company overview
                              5.3.10.2. Financial performance
                              5.3.10.3. Product benchmarking
                              5.3.10.4. Strategic initiatives
                          5.3.11. Lingand Pharmaceuticals
                              5.3.11.1. Company overview
                              5.3.11.2. Financial performance
                              5.3.11.3. Product benchmarking
                              5.3.11.4. Strategic initiatives
                          5.3.12. Thermo Fisher Scientific, Inc.
                              5.3.12.1. Company overview
                              5.3.12.2. Financial performance
                              5.3.12.3. Product benchmarking
                              5.3.12.4. Strategic initiatives
                          5.3.13. AbbVie, Inc.
                              5.3.13.1. Company overview
                              5.3.13.2. Financial performance
                              5.3.13.3. Product benchmarking
                              5.3.13.4. Strategic initiatives
                          5.3.14. West Pharmaceutical Services
                              5.3.14.1. Company overview
                              5.3.14.2. Financial performance
                              5.3.14.3. Product benchmarking
                              5.3.14.4. Strategic initiatives

List of Tables

Table 1. List of abbreviations
Table 2. U.S. Pharmaceutical Contract Manufacturing and Research Services Market, by Service, (USD Billion) 2018 - 2030

List of Figures

Fig. 1 U.S. pharmaceutical contract manufacturing and research services market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. pharmaceutical contract manufacturing and research services market: Service outlook and key takeaways
Fig. 16 U.S. pharmaceutical contract manufacturing and research services market: Service movement analysis
Fig. 17 Manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 18 API/bulk drugs market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 19 Advances drug delivery formulations packaging market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Packaging market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Finished dose formulations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Solid formulations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Liquid formulations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Semi-solid formulations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 Research market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Vaccines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Inflammation & immunology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Neuroscience market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Company market share analysis, 2023
Fig. 33 Strategic framework